Coromandel International FY 2025-26 Annual Report: Record Revenue, Strategic Acquisitions and ESG Milestones
Coromandel International filed its FY 2025-26 Integrated Annual Report reporting record standalone revenue of ₹30,531 crore and consolidated revenue of ₹31,480 crore with EBITDA of ₹3,232 crore and PAT of ₹2,009 crore. The company achieved highest-ever fertiliser sales of 42.8 lakh MT DAP/NPK and 8.4 lakh MT SSP, completed the ₹820 crore NACL acquisition, commissioned backward integration plants at Kakinada, and received Responsible Care Certification, with total dividend of ₹11 per share for the year.

*this image is generated using AI for illustrative purposes only.
Coromandel International Limited has filed its Integrated Annual Report for the financial year ended March 31, 2026, with stock exchanges pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report covers the company's 64th Annual General Meeting, scheduled for Thursday, July 23, 2026 at 3:30 PM IST via Video Conferencing, and reflects a year of strong operational performance, strategic acquisitions, and significant capital deployment across core and growth businesses.
Financial Performance: Standalone and Consolidated Highlights
Coromandel delivered robust financial results in FY 2025-26 despite a challenging external environment marked by raw material inflation, rupee depreciation, subsidy mismatches, and geopolitical disruptions in the Middle East. The following table summarises key standalone and consolidated financial metrics:
| Metric: | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Standalone Revenue from Operations: | ₹30,531 crore | ₹24,064 crore |
| Standalone PBT: | ₹2,743 crore | ₹2,585 crore |
| Standalone PAT: | ₹2,009 crore | ₹1,941 crore |
| Standalone EPS: | ₹68 per share | ₹65.96 per share |
| Consolidated Revenue: | ₹31,480 crore | — |
| Consolidated EBITDA: | ₹3,232 crore | — |
| Total Income (Consolidated): | ₹30,882 crore | ₹24,428 crore |
| EBITDA (Consolidated, incl. Other Income): | ₹3,467 crore | ₹3,020 crore |
| Net Worth: | ₹12,474 crore | ₹10,999 crore |
| Book Value per Share: | ₹423 | ₹373 |
| Dividend per Share: | ₹11 | — |
The Board recommended a final dividend of ₹2 per equity share for FY 2025-26, in addition to the interim dividend of ₹9 per equity share paid during the year, bringing the total dividend to ₹11 per equity share. The total dividend outflow for the year amounts to ₹324 crore, inclusive of Tax Deducted at Source. The following table presents multi-year consolidated financial trends:
| Particulars: | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
| Total Income (₹ crore): | 14,231 | 19,231 | 29,784 | 22,308 | 24,428 | 30,882 |
| EBITDA incl. Other Income (₹ crore): | 2,044 | 2,179 | 3,093 | 2,680 | 3,020 | 3,467 |
| PAT (₹ crore): | 1,313 | 1,412 | 2,035 | 1,719 | 1,941 | 2,009 |
| EBITDA Margin (%): | 14% | 11% | 10% | 12% | 12% | 10% |
| PAT (%): | 9% | 7% | 7% | 8% | 8% | 6.5% |
| Book Value per Share (INR): | 178 | 215 | 268 | 319 | 373 | 423 |
| Earnings per Share (INR): | 45 | 48 | 69 | 58 | 66 | 68 |
| Debt-Equity Ratio: | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Business Performance: Fertilisers, Crop Protection, and Retail
The fertiliser business registered its highest-ever sales volumes during FY 2025-26, with DAP and NPK volumes reaching 42.8 lakh metric tonnes and SSP sales at 8.4 lakh metric tonnes — the highest ever for the SSP segment. Coromandel affirmed its position as India's largest phosphatic fertiliser company by Point of Sale (PoS) sales volume for the second consecutive year. The company commissioned a 2,000 TPD Sulphuric Acid plant and a 650 TPD Phosphoric Acid plant at Kakinada in Q4, strengthening backward integration. The Kakinada facility is on course to reach a total capacity of 30 lakh tonnes upon commissioning of the 7.5 lakh tonne NPK granulation train (Train H), expected by Q4 FY 2026-27.
The Crop Protection Chemicals (CPC) segment delivered record profitability, with CPC EBITDA crossing ₹500 crore, supported by improved domestic B2B and export margins and the Mancozeb platform. A 9,000 MT Mancozeb project at Dahej was commissioned in January 2026. The company completed the acquisition of a 53.13% controlling stake in NACL Industries Limited for ₹820 crore at ₹76.7 per share. NACL delivered revenue growth of 28% to ₹1,584 crore during the year.
The Retail business expanded its network with a net addition of 320 new stores, taking the total store count to approximately 1,200. Retail revenue grew by 31% and EBITDA by 29%. Nano fertilisers recorded 76% EBITDA growth, while the Bio segment delivered 27% EBITDA growth. The Nano DAP segment achieved approximately 50% market share in India.
Capital Expenditure and Strategic Investments
Capital expenditure during FY 2025-26 stood at ₹1,337 crore, directed towards capacity expansion, backward integration, and strengthening growth platforms. Between FY21 and FY26, the company made investment commitments for organic and inorganic expansion of close to ₹7,000 crore. The sulphuric acid plant at Vizag, commissioned in FY24, has already generated savings of nearly ₹400 crore. Coromandel increased its equity stake in Baobab Mining and Chemicals Corporation (BMCC), Senegal, to 71.5%, strengthening raw material security for its phosphoric acid operations.
| Investment Highlight: | Details |
|---|---|
| NACL Acquisition Cost: | ₹820 crore at ₹76.7 per share |
| NACL Rights Issue Subscription: | ~₹250 crore |
| Kakinada PA & SA Plant Completion: | March 2026 |
| Dahej Mancozeb Plant Capacity: | 9,000 MT, commissioned January 2026 |
| Capital Expenditure FY26: | ₹1,337 crore |
| BMCC Stake: | 71.5% |
| Kakinada Target Capacity (post H-Train): | 30 lakh tonnes |
Key Financial Ratios
The following table presents key financial ratios for FY 2025-26 and FY 2024-25:
| Ratio: | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Debtors' Turnover (No. of Days): | 43 | 48 |
| Inventory Turnover (No. of Days): | 90 | 95 |
| Debt Service Coverage Ratio: | 10.79 | 11.47 |
| Current Ratio: | 1.58 | 1.96 |
| Debt-Equity Ratio: | 0.02 | 0.00 |
| Operating Profit Margin % (EBITDA): | 10.16 | 11.04 |
| Net Profit Margin %: | 6.58 | 8.07 |
| Return on Equity %: | 17.11 | 19.03 |
Tax Contribution
During the year, Coromandel reported an effective tax rate of 27% and paid ₹724 crore in cash taxes. The following table summarises the tax reporting for recent years:
| Financial Reporting: | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Earnings before Tax (₹ crore): | 2,743 | 2,585 | 2,272 |
| Reported Taxes (₹ crore): | 724 | 644 | 553 |
| Effective Tax Rate (%): | 27% | 25% | 24% |
| Cash Tax Rate (%): | 26% | 26% | 27% |
ESG, Safety, and Governance
Coromandel was awarded the Responsible Care Certification by the Indian Chemical Council in April 2026, valid through March 2029, becoming the 97th company in India to earn this distinction. The Kakinada facility received the British Safety Council's Sword of Honour. The Total Recordable Injury Rate (TRIR) stood at 0.25. The company's Scope 1 and Scope 2 GHG emissions stood at 2,78,564 tCO₂e for FY 2025-26, with total Scope 3 emissions at 5,159,431 tCO₂e. Water recycled and reused increased by 57% to 6,23,921 KL. The company maintained 100% EPR compliance for plastic waste, managing 18,433 MT under its EPR obligation. CSR spend for the year stood at ₹49 crore, reaching more than 15.28 lakh beneficiaries.
The Board as on March 31, 2026 comprised 10 Directors, with 6 Independent Directors, reflecting 60% independent representation. As on April 30, 2026, the Board comprised 12 Members, consisting of 6 Executive Directors and 6 Independent Directors. The company's credit ratings were reaffirmed at CRISIL AAA (Stable) and IND AAA (Stable), with short-term ratings at CRISIL A1+ and IND A1+. The 64th Annual General Meeting is scheduled for July 23, 2026, with a record date of July 16, 2026 for the final dividend.
Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE169A01031/0b1e319e-e302-4af7-a4a8-f0981843b925.pdf
Historical Stock Returns for Coromandel International
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.59% | +0.02% | +13.66% | -10.88% | -20.44% | +121.25% |
How will the commissioning of the new NPK granulation train in Q4 FY 2026-27 impact Coromandel's market share and production capacity in the upcoming fiscal year?
What synergies and revenue enhancements are expected following the strategic acquisition of a 53.13% controlling stake in NACL Industries?
Given the decline in net profit margin to 6.58% despite revenue growth, what strategies will management employ to protect margins against persistent raw material inflation and rupee depreciation?































